- Home
- FATE vs SDHC Comparison
FATE vs SDHC Comparison
Compare FATE & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FATE | SDHC |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 162.0M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FATE | SDHC |
|---|---|---|
| Price | $1.46 | $17.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $3.92 | ★ $16.70 |
| AVG Volume (30 Days) | ★ 1.5M | 48.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | $13,631,000.00 | ★ $975,463,000.00 |
| Revenue This Year | N/A | $0.58 |
| Revenue Next Year | N/A | $6.61 |
| P/E Ratio | ★ N/A | $21.72 |
| Revenue Growth | N/A | ★ 27.57 |
| 52 Week Low | $0.66 | $15.00 |
| 52 Week High | $1.94 | $23.73 |
Technical Indicators
Market Signals| Indicator | FATE | SDHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.98 | 38.64 |
| Support Level | $1.31 | $16.97 |
| Resistance Level | $1.40 | $19.82 |
| Average True Range (ATR) | 0.09 | 1.00 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 84.72 | 2.11 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.